Dr. Bruce Morimoto has been appointed executive director of Applied Translational Medicine at Celerion. Dr. Morimoto is responsible for developing and implementing strategies for patient populations in early clinical research and clinical pharmacology studies. Dr. Morimoto will also lead the external studies management and clinical monitoring services teams.    Dr. Morimoto has more than 20 years of experience in the pharmaceutical and biotechnology, and CRO industries. He joins the company from...